According to the owner of the venue, the "audience thought it was part of his set" A stand-up comedian died onstage during a performance Thursday evening. Ian Cognito, a British comic, fell ill during ...

Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics By merging ...

Add Yahoo as a preferred source to see more of our stories on Google. British comedian Ian Cognito died performing a stand-up routine Thursday at the Atic bar in Bicester, England; however, according ...

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...

Cognito Therapeutics’ sensory stimulation device slowed the decline in daily functioning and cognitive abilities over six months compared to sham treatment in Alzheimer’s disease patients. In new data ...

New data from Cognito Therapeutics has indicated that its Spectris device increases cerebrospinal fluid (CSF) HDL-like lipid transport particles, suggesting the neuromodulation therapy prompts a ...

Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and ...

Riding high on early clinical trial results showing that its neuromodulation headset can improve memory and cognition and slow the deterioration of white matter in the brains of people with ...

Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a catchall term that can carry stigma. The term “dementia” is an umbrella term ...

CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world ...

For decades, biotech companies have struggled to develop treatments for Alzheimer's disease, a disorder that causes loss of memory and other mental functions and affects roughly 6.5 million Americans.

In a sea of failed Alzheimer’s treatments, a digital health startup is hoping to find answers in a noninvasive treatment using light and sound. Cognito was founded by MIT Professors Li-Huei Tsai and ...